Cleared Traditional

K082395 - GLUCOSE METER-CHECK CONTROL SOLUTION FO...

K082395 is the FDA 510(k) clearance for GLUCOSE METER-CHECK CONTROL SOLUTION FO... by Bionostics, Inc.. It is a Class 1 Chemistry device (product code JJX) cleared through the Traditional 510(k) pathway after a 30-day FDA review.

K082395 · Bionostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2008
Decision
30d
Days
Class 1
Risk

K082395 is an FDA 510(k) clearance for the GLUCOSE METER-CHECK CONTROL SOLUTION FOR BAYER ASCENSIA BLOOD GLUCOSE METER, .... Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Bionostics, Inc. (Devens, US). The FDA issued a Cleared decision on September 18, 2008 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bionostics, Inc. devices

Submission Details

510(k) Number K082395 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 19, 2008
Decision Date September 18, 2008
Days to Decision 30 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 88d · This submission: 30d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 274
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K082395.
ADVIA CENTAUR DHEAS MASTER CURVE MATERIALS
K091123 · Siemens Healthcare Diagnostics · Aug 2009
ELECSYS RUBELLA IGG CALCHECK
K090311 · Roche Diagnostics · May 2009
ELECSYS TOXO IGG CALCHECK
K083655 · Roche Diagnostics · Feb 2009
ELECSYS ANTI-TSHR CALCHECK
K080643 · Roche Diagnostics · Aug 2008
ELECSYS PROBNP II CALCHECK
K080147 · Roche Diagnostics Corp. · Feb 2008
PRECINORM CK-MB AND PRECIPATH CK-MB CONTROLS
K062972 · Roche Diagnostics Corp. · Oct 2006